ÂÜÀòÂÒÂ×

Shannon Capwell's work experience begins in 2016 when they worked as an Undergraduate Student Researcher at the University of Rhode Island Feinstein Providence Campus, focusing on antibody-dependent enhancement in Dengue Fever. In 2017 and 2018, they were an Undergraduate Research Fellow at RI-INBRE, where they participated in summer research programs investigating microbial interactions in the human oral microbiome. Starting in 2019, Shannon joined Rubius Therapeutics as a Quality Control Microbiology Sampling Analyst, eventually becoming a Quality Control Analyst II. In 2022, they moved to Neurotech Pharmaceuticals, Inc. as a Quality Control Analyst II in Microbiology. Shannon also worked as a Chemistry Tutor at the University of Rhode Island from 2017 to 2019, providing guidance and study strategies to students.

Shannon Capwell pursued their education in the field of Microbiology, General at the University of Rhode Island. Shannon attended the university from the year 2015 to 2019 and obtained a degree in Cell and Molecular Biology.